Sigyn Therapeutics Statistics
Total Valuation
SIGY has a market cap or net worth of $6.00 million. The enterprise value is $8.62 million.
| Market Cap | 6.00M |
| Enterprise Value | 8.62M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SIGY has 1.26 million shares outstanding. The number of shares has decreased by -96.80% in one year.
| Shares Outstanding | 1.26M |
| Shares Change (YoY) | -96.80% |
| Shares Change (QoQ) | -1.51% |
| Owned by Insiders (%) | 53.59% |
| Owned by Institutions (%) | 7.61% |
| Float | 476,249 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 414.18 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 594.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,102.09% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $2,898 |
| Profits Per Employee | -$712,598 |
| Employee Count | 5 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.16 |
Taxes
In the past 12 months, SIGY has paid $1.21 million in taxes.
| Income Tax | 1.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +124.06% in the last 52 weeks. The beta is -1.09, so SIGY's price volatility has been lower than the market average.
| Beta (5Y) | -1.09 |
| 52-Week Price Change | +124.06% |
| 50-Day Moving Average | 5.32 |
| 200-Day Moving Average | 6.14 |
| Relative Strength Index (RSI) | 46.67 |
| Average Volume (20 Days) | 3 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SIGY had revenue of $14,492 and -$3.56 million in losses. Loss per share was -$1.60.
| Revenue | 14,492 |
| Gross Profit | 6,728 |
| Operating Income | -2.56M |
| Pretax Income | -3.56M |
| Net Income | -3.56M |
| EBITDA | -2.56M |
| EBIT | -2.56M |
| Loss Per Share | -$1.60 |
Balance Sheet
The company has $32,838 in cash and $2.65 million in debt, giving a net cash position of -$2.62 million or -$2.07 per share.
| Cash & Cash Equivalents | 32,838 |
| Total Debt | 2.65M |
| Net Cash | -2.62M |
| Net Cash Per Share | -$2.07 |
| Equity (Book Value) | -4.02M |
| Book Value Per Share | -3.18 |
| Working Capital | -4.10M |
Cash Flow
| Operating Cash Flow | -1.06M |
| Capital Expenditures | n/a |
| Free Cash Flow | -1.06M |
| FCF Per Share | -$0.86 |
Margins
Gross margin is 46.43%, with operating and profit margins of -17,692.72% and -24,585.90%.
| Gross Margin | 46.43% |
| Operating Margin | -17,692.72% |
| Pretax Margin | -24,585.90% |
| Profit Margin | -24,585.90% |
| EBITDA Margin | -17,639.17% |
| EBIT Margin | -17,692.74% |
| FCF Margin | -7,288.50% |
Dividends & Yields
SIGY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 96.80% |
| Shareholder Yield | 96.80% |
| Earnings Yield | -59.36% |
| FCF Yield | -17.60% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 1:40.
| Last Split Date | Jan 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
SIGY has an Altman Z-Score of -92.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -92.91 |
| Piotroski F-Score | 3 |